Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FblcHCluNQAygpnI3w7sqQgvaSeA.uncropped.jpg&w=3840&q=75)
Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 54 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check8 days agoChange DetectedDifference0.2%
- Check10 days agoChange DetectedDifference0.2%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check15 days agoChange DetectedDifference0.2%
- Check16 days agoChange DetectedDifference0.2%
Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.